APGRADA Trademark

Trademark Overview

On Wednesday, May 15, 2019, a trademark application was filed for APGRADA with the United States Patent and Trademark Office. The USPTO has given the APGRADA trademark a serial number of 79263061. The federal status of this trademark filing is REGISTERED as of Tuesday, December 10, 2019. This trademark is owned by Novartis AG. The APGRADA trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery devices, namely, injection devices for pharmaceuticals, injection devices for administering drugs
apgrada

General Information

Serial Number79263061
Word MarkAPGRADA
Filing DateWednesday, May 15, 2019
Status700 - REGISTERED
Status DateTuesday, December 10, 2019
Registration Number5929556
Registration DateTuesday, December 10, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 24, 2019

Trademark Statements

Translation of Words in MarkThe wording "APGRADA" has no meaning in a foreign language.
Goods and ServicesDrug delivery devices, namely, injection devices for pharmaceuticals, injection devices for administering drugs

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, July 19, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Thursday, July 25, 2019ASSIGNED TO EXAMINER
Thursday, July 18, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 23, 2019APPLICATION FILING RECEIPT MAILED
Thursday, July 25, 2019NON-FINAL ACTION WRITTEN
Friday, July 26, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 20, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 20, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, August 20, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 20, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, August 22, 2019REFUSAL PROCESSED BY MPU
Thursday, August 22, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, September 24, 2019PUBLISHED FOR OPPOSITION
Tuesday, September 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, October 5, 2019NOTIFICATION PROCESSED BY IB
Tuesday, December 10, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 10, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, March 21, 2020FINAL DISPOSITION PROCESSED
Saturday, March 21, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 10, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, December 10, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, September 6, 2019REFUSAL PROCESSED BY IB

Related Keywords

apgrada devices injection administering pharmaceuticals drugs namely delivery drug